193. Prader-Willi syndrome Clinical trials / Disease details

Clinical trials : 111 / Drugs : 120 - (DrugBank : 30) / Drug target genes : 51 - Drug target pathways : 103

22 trials found

diseases per page:

Showing 1 to 10 of 22 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002385-12-NL (EUCTR)	26/08/2021	08/09/2020	Oxytocin treatment in neonates and infants aged from 0 to 3 months with prader-willi syndrome	Oxytocintreatment in neonates and infants aged from 0 to 3 months with prader-willi syndrome: a stud ...	Prader-Willi Syndrom;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Not Recruiting			Female: yes Male: yes	48	Phase 3	France;Belgium;Germany;Netherlands
2	EUCTR2019-002385-12-DE (EUCTR)	07/07/2021	21/04/2021	OXYTOCIN TREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME	OXYTOCINTREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME: A STUD ...	Prader-Willi Syndrome;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 3	France;Belgium;Netherlands;Germany
3	NCT04283578 (ClinicalTrials.gov)	March 10, 2020	19/2/2020	Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome	OxytocinTreatment in Neonates and Infants Aged From 0 to 3 Months With Prader-Willi Syndrome : a Stu ...	Prader-Willi Syndrome	Drug: OT;Drug: Placebo comparator	University Hospital, Toulouse	International Clinical Trials Association;Epidemiological and Clinical Research Information Network	Active, not recruiting	N/A	92 Days	All	48	Phase 3	France
4	EUCTR2019-002385-12-FR (EUCTR)	27/08/2019	12/06/2019	OXYTOCIN TREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME	OXYTOCINTREATMENT IN NEONATES AND INFANTS AGED FROM 0 TO 3 MONTHS WITH PRADER-WILLI SYNDROME: A STUD ...	Prader-Willi Syndrom;Therapeutic area: Diseases [C] - Hormonal diseases [C19]	Product Name: Oxytocin INN or Proposed INN: OXYTOCIN Other descriptive name: OXYTOCIN	University Hospital of Toulouse	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	France
5	NCT03197662 (ClinicalTrials.gov)	April 11, 2018	19/6/2017	Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome	Phase 2 Study: Intranasal Oxytocinvs. Placebo for the Treatment of Hyperphagia in Children and Adole ...	Prader-Willi Syndrome;Hyperphagia	Drug: Intranasal Oxytocin (IN-OXT);Drug: Matched Placebo	Montefiore Medical Center	NULL	Recruiting	5 Years	17 Years	All	50	Phase 2	United States
6	EUCTR2017-003423-30-NL (EUCTR)	12/12/2017	04/10/2017	Intranasal administration of oxytocin in children with Prader-Willi syndrome	Randomized, double-blind, placebo-controlled oxytocinand dose-response trial in children with Prader ...	Prader-Willi syndrome MedDRA version: 20.0;Level: PT;Classification code 10036476;Term: Prader-Willi ...	Trade Name: Syntocinon nasal spray Product Name: oxytocin Product Code: oxytocin	Dutch Growth Research Foundation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	33	Phase 2;Phase 3	Netherlands
7	NCT03245762 (ClinicalTrials.gov)	August 1, 2017	7/8/2017	Intranasal Oxytocin for Infants With Prader-Willi Syndrome	Intranasal Oxytocinfor Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional P ...	Prader-Willi Syndrome	Drug: Oxytocin;Drug: Placebo	University of Florida	Prader-Willi Syndrome Association	Completed	N/A	6 Months	All	15	Phase 1/Phase 2	United States
8	NCT03081832 (ClinicalTrials.gov)	January 2017	10/3/2017	Follow-up of Prader Willi Syndrome Infants Treated by Oxytocinand Comparison With Not-treated Infant ...	Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study (Repeated A ...	Prader-Willi Syndrome	Drug: Oxytocin;Other: Control	University Hospital, Toulouse	NULL	Completed	3 Years	4 Years	All	34	N/A	France
9	EUCTR2016-003820-22-NL (EUCTR)	22/12/2016	12/10/2016	Intranasal administration of oxytocin in children with Prader-Willi Syndrome	Intranasal administration of oxytocinin children with Prader-Willi Syndrome. A randomized, open-labe ...	Prader-Willi syndrome MedDRA version: 19.0;Level: PT;Classification code 10036476;Term: Prader-Willi ...	Trade Name: Syntocinon nasal spray Product Name: oxytocin Product Code: oxytocin	Dutch Growth Research Foundation	NULL	Not Recruiting			Female: yes Male: yes		Phase 3	Netherlands
10	NCT03114371 (ClinicalTrials.gov)	November 28, 2016	10/3/2017	Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years	Effects of Intranasal Administrations of Oxytocinon Behavioural Troubles, Hyperphagia and Social Ski ...	Prader-Willi Syndrome	Drug: Oxytocin;Drug: Placebo	University Hospital, Toulouse	NULL	Completed	3 Years	12 Years	All	40	N/A	France

First Previous1 2 3Next Last